Veradigm - MDRX STOCK NEWS

Allscripts Healthcare Solutions (NASDAQ:MDRX) will release its financial results for Q1 2022 on May 5, 2022, after market close. The earnings announcement will be followed by a conference call at 4:30 p.m. Eastern Time to discuss the results. Interested participants can access the call through the Allscripts Investor Relations website or by dialing 877-269-7756. A replay will be available for four weeks post-call. Allscripts specializes in healthcare information technology solutions aimed at improving clinical and operational outcomes.

Allscripts (NASDAQ: MDRX) has relaunched its Application Store, now called the Allscripts App Expo, enhancing accessibility for clients to discover certified applications developed through the Allscripts Developer Program. The platform expands the visibility of certified solutions built with Allscripts APIs, promoting interoperability. Allscripts continues to support connectivity across various environments and specialties, with hundreds of certified apps available. The company’s commitment to innovation is evidenced by participation in upcoming industry events, including ViVE 2022 and HIMSS 2022.

Allscripts Healthcare Solutions (NASDAQ: MDRX) has agreed to sell its Hospitals and Large Physician Practices business segment to Constellation Software Inc. through its subsidiary N. Harris Computer Corporation for up to $700 million. The deal consists of a fixed payment of $670 million at closing and contingent consideration of up to $30 million based on performance over two years. This transaction aims to enhance focus and opportunities for Allscripts' clients and shareholders, with the sale expected to finalize in the second quarter, pending regulatory approval.

Veradigm, part of Allscripts Healthcare Solutions (MDRX), has announced a partnership with the U.S. Social Security Administration (SSA) to enhance the speed of health record retrieval. This new system will reduce retrieval time from weeks or days to just minutes for millions of patient-authorized requests. The Veradigm eChart Courier™ will automate the request process, decreasing administrative burdens on healthcare providers while improving the experience for SSA applicants.

Allscripts Healthcare Solutions (MDRX) reported a fourth quarter 2021 GAAP diluted EPS of $0.68, with non-GAAP diluted EPS at $0.79. Bookings rose 21% to $219 million compared to Q4 2020. The company generated $66 million in cash flow from continuing operations, while total revenue increased to $392 million, up from $386 million in the same quarter last year. Net income for Q4 2021 was $87 million, a decrease from $728 million in Q4 2020, primarily due to prior year gains from divestitures. Looking forward, Allscripts anticipates 2022 consolidated free cash flow between $165 million and $175 million and revenue growth of 1% to 2%.

Allscripts Healthcare Solutions (MDRX) has announced its preliminary financial results for Q4 and the full year ended December 31, 2021. Revenue for Q4 is projected at $390M-$395M, while the full year GAAP operating income is expected between $70M and $75M. The company anticipates Adjusted EBITDA of $295M-$300M, exceeding previous guidance. Cash flow from continuing operations is expected at $245M-$250M, with free cash flow at $165M-$170M. Additionally, Allscripts has approved a new share repurchase program of up to $250M, replacing its previous $350M program.

Allscripts (NASDAQ: MDRX) has partnered with Next Level Urgent Care to implement its TouchWorks® electronic health record (EHR) platform across all their Houston locations. This initiative aims to enhance EHR workflows, improve analytics, and streamline patient care. With Next Level being Texas's first accredited urgent care center, the integration of Allscripts' solutions and Microsoft Azure services is expected to promote quality healthcare. The partnership underscores Allscripts' commitment to driving better clinical outcomes and operational efficiencies.

Allscripts Healthcare Solutions (Nasdaq: MDRX) reported significant financial growth for Q3 2021, with GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.27, marking a 145% increase year-over-year. The company generated $57 million in cash flow from continuing operations and $35 million in free cash flow. Total bookings reached $166 million, up from $160 million in Q3 2020, while revenue increased to $369 million compared to $366 million in the previous year. Allscripts has revised its 2021 Adjusted EBITDA outlook to between $275 million and $285 million.

Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will release its financial results for Q3 2021 on November 4, 2021, after market close. A conference call to discuss these results is scheduled for 4:30 p.m. ET on the same day. Interested participants can join via the Allscripts Investor Relations website or by phone. A replay will be accessible shortly after the call for four weeks. Allscripts is a leader in healthcare IT solutions, focusing on enhancing clinical, financial, and operational outcomes within the healthcare sector.